These data implicate sex differences in microglial activation in the modulation of energy homeostasis and identify CX3CR1 signalling as a potential therapeutic target for the treatment of obesity. The gene discussed is CX3CR1; the disease is obesity due to melanocortin 4 receptor deficiency.